Dfx | List of Frontiers open access articles

Original Research

Published on 13 May 2020

Desferrioxamine Supports Metabolic Function in Primary Human Macrophages Infected With Mycobacterium tuberculosis

in Molecular Innate Immunity

James Joseph Phelan
Kate McQuaid
Colin Kenny
Karl Michael Gogan
Dónal J. Cox
Sharee Ann Basdeo
Seónadh O’Leary
Simone Christa Tazoll
Cilian Ó Maoldomhnaigh
Mary P. O’Sullivan

Frontiers in Immunology

doi 10.3389/fimmu.2020.00836

10,920 views
38 citations

Original Research

Published on 03 Mar 2022

Minimally Invasive Surgery for ICH Evacuation Combined With Deferoxamine Treatment Increased Perihematomal Claudin-5 and ZO-1 Expression Levels and Decreased BBB Permeability in Rabbits

in Stroke

Siying Ren
Shanshan Han
Likun Wang
Yuanxin Huang
Jing Wu
Guofeng Wu

Frontiers in Neurology

doi 10.3389/fneur.2022.835494

3,821 views
15 citations

Original Research

Published on 10 Feb 2023

Catalytic conversion of diformylxylose to furfural in biphasic solvent systems

in Bioprocess Engineering

Lizhen Huang
Zelun Bian
Dalin Li
Xin Cheng
Xiaolin Luo
Li Shuai
Jing Liu

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2023.1146250

3,680 views
5 citations

Original Research

Published on 28 Nov 2022

A DFX-based iron nanochelator for cancer therapy

in Nanobiotechnology

Peng Liu
Qiang Wang
Kuan Li
Bo Bi
Ying-Fei Wen
Miao-Juan Qiu
Jing Zhao
Bin-Bin Li
Chang-Hua Zhang
Yu-Long He

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2022.1078137

3,462 views
4 citations

Case Report

Published on 23 Oct 2024

Case report: Acute liver failure during deferasirox therapy and the potential role of pharmacogenetics

in Pharmacogenetics and Pharmacogenomics

Belén García-Fariña
Lydia Rink
Virginia Santarini
Marco Westkemper
Christian Dohna-Schwake
Birte Möhlendick

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477755

4,168 views
6 citations

Clinical Trial

Published on 19 Nov 2024

Comparison of the effects of deferasirox film-coated tablets (Jadenu®) and deferasirox dispersible tablets (Exjade®) in patients with beta thalassemia major: a preliminary report of the effects on the satisfaction, convenience, cardiac/liver MRI T2*, serum ferritin level, and biochemical profiles

in Obstetric and Pediatric Pharmacology

Mahya Mobinikhaledi
Vahid Falahati
Amin Tajerian
Amir Almasi Hashiani
Kazem Ghaffari
Ali Ghasemi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438611

4,346 views
1 citation

Original Research

Published on 07 Dec 2020

The Blood Component Iron Causes Neuronal Apoptosis Following Intracerebral Hemorrhage via the PERK Pathway

in Stroke

Muyao Wu
Rong Gao
Baoqi Dang
Gang Chen

Frontiers in Neurology

doi 10.3389/fneur.2020.588548

3,190 views
7 citations

Articles

Desferrioxamine Supports Metabolic Function in Primary Human Macrophages Infected With Mycobacterium tuberculosis

Minimally Invasive Surgery for ICH Evacuation Combined With Deferoxamine Treatment Increased Perihematomal Claudin-5 and ZO-1 Expression Levels and Decreased BBB Permeability in Rabbits

Catalytic conversion of diformylxylose to furfural in biphasic solvent systems

A DFX-based iron nanochelator for cancer therapy

Case report: Acute liver failure during deferasirox therapy and the potential role of pharmacogenetics

Comparison of the effects of deferasirox film-coated tablets (Jadenu®) and deferasirox dispersible tablets (Exjade®) in patients with beta thalassemia major: a preliminary report of the effects on the satisfaction, convenience, cardiac/liver MRI T2*, serum ferritin level, and biochemical profiles

The Blood Component Iron Causes Neuronal Apoptosis Following Intracerebral Hemorrhage via the PERK Pathway